ST. LOUIS, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it ...

XCath, a medical device company dedicated to pioneering neuro-endovascular surgical robotics, announced today the successful first-in-human use of its EVR robotic system to treat three patients with ...

In a historic leap for neurovascular medicine, XCath’s EVR robotic system has successfully treated three patients with ...

Stereotaxis STXS recently secured FDA 510(k) clearance for GenesisX, its next-generation robotic system designed to make ...

XCath today announced the successful first-in-human use of its EVR robotic system to treat three patients with complex brain ...

Stereotaxis received clearance from the Food & Drug Administration for its latest surgical robotic system, GenesisX. The maker of surgical robots on Monday said the GenesisX builds upon the benefits ...

Stereotaxis announced today that it received FDA 510(k) clearance for its next-generation GenesisX surgical robot.

Immune checkpoint inhibitors in lung cancer: A retrospective cohort analysis of cardiovascular safety profiles. Analysis of treatment characteristics in TH-S1 robotic-guided percutaneous puncture ...

Robot navigation and human-robot interaction are rapidly evolving fields that focus on how robots can effectively and safely navigate environments shared with humans. As robots become more integrated ...

Researchers have designed an intelligent household robot capable of autonomous navigation, object detection, and sorting. This robot, equipped with advanced technologies like depth cameras, YOLOv11 ...